US 7714109
Combinations and kits for cancer treatment using selected antibodies to aminophospholipids
granted A61KA61K2039/505A61K39/395
Quick answer
US patent 7714109 (Combinations and kits for cancer treatment using selected antibodies to aminophospholipids) held by The Board of Regents of the University of Texas System expires Mon May 06 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue May 11 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 06 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 53
- CPC classes
- A61K, A61K2039/505, A61K39/395, A61K39/39558, A61K47/62